Lung Deposition Via Different Inhalation Devices

• Status: Completed
• Trial end date: 2009-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the deposition of budesonide to the lung after inhalation with 5 different devices and to relate the findings to in vitro properties of inhaled budesonide.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: AstraZeneca
• Treatments: Budesonide

Criteria

Inclusion Criteria:

• Provision of informed consent prior to any study specific procedures

• BMI between 18 and 30 kg/m2

• Non-smokers/non-snuffers

Exclusion Criteria:

• Pregnant and/or lactating women

• Use of oral contraceptives or hormonal implants

• Known or suspected hypersensitivity to glucocorticosteroids, inhaled lactose, or other excipients in study drugs